Controversy about alleged adverse events following immunization (AEFI) with HPV vaccine have led to extensive reductions in vaccine acceptance. By making comparisons, authors conclude that any causal links between HPV vaccine and AEFIs, as well as the underlying molecular basis for the links will be revealed and can provide an objective basis for evaluating HPV vaccine safety and for identifying biomarkers for individuals at risk of developing AEFI with HPV vaccination.